Cargando…

Potential Utility of Natural Killer Cells for Eliminating Cells Harboring Reactivated Latent HIV-1 Following the Removal of CD8(+) T Cell-Mediated Pro-Latency Effect(s)

An impediment to curing HIV-1 infection is the persistence of latently infected cells in ART-treated people living with HIV (PLWH). A key strategy for curing HIV-1 infection is to activate transcription and translation of latent virus using latency reversing agents (LRAs) and eliminate cells harbori...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoury, Georges, Kulpa, Deanna A., Parsons, Matthew S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402732/ https://www.ncbi.nlm.nih.gov/pubmed/34452317 http://dx.doi.org/10.3390/v13081451

Ejemplares similares

Elimination In Vivo of Developing T Cells by Natural Killer Cells
por: Schott, Eckart, et al.
Publicado: (2003)

Control of Gammaherpesvirus Latency by Latent Antigen-Specific Cd8(+) T Cells
por: Usherwood, Edward J., et al.
Publicado: (2000)

Latency reversal plus natural killer cells diminish HIV reservoir in vivo
por: Kim, Jocelyn T., et al.
Publicado: (2022)

Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV
por: Ghofrani, Joshua, et al.
Publicado: (2023)

T Cells and the Regulation of Herpes Simplex Virus Latency and Reactivation
por: Nash, Anthony A.
Publicado: (2000)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency
por: Rawlings, Stephen A., et al.
Publicado: (2015)

Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8(+) Killer T Cells
por: Subklewe, Marion, et al.
Publicado: (2001)

Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4(+) T Cells
por: Kulpa, Deanna A., et al.
Publicado: (2019)

Herpes simplex latent infection: quantitation of latency-associated transcript-positive neurons and reactivable neurons.
por: Tenser, R. B., et al.
Publicado: (1989)

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
por: Garrido, Carolina, et al.
Publicado: (2016)

Modulation of host cell signaling during cytomegalovirus latency and reactivation
por: Smith, Nicholas A., et al.
Publicado: (2021)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
por: Rasmussen, Thomas A., et al.
Publicado: (2013)

Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells
por: Vyas, Maulik, et al.
Publicado: (2023)

In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4(+) T Cells Harboring Reactivated Human Immunodeficiency Virus
por: Desimio, Maria Giovanna, et al.
Publicado: (2018)

Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells
por: Saleh, Suha, et al.
Publicado: (2011)

Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
por: Wojcik, Ewa, et al.
Publicado: (2017)

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
por: Lee, Wen Shi, et al.
Publicado: (2015)

Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors
por: Furtado Milão, Joana, et al.
Publicado: (2022)

Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells
por: Engelberg, Shira, et al.
Publicado: (2021)

The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons
por: Nicoll, Michael P., et al.
Publicado: (2016)

The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T(CM) Cell Model of Latency
por: Sarabia, Indra, et al.
Publicado: (2021)

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model
por: Mohammadi, Pejman, et al.
Publicado: (2014)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Stern, Lauren, et al.
Publicado: (2019)

Regulatory B Cells Inhibit Cytotoxic T Lymphocyte (CTL) Activity and Elimination of Infected CD4 T Cells after In Vitro Reactivation of HIV Latent Reservoirs
por: Siewe, Basile, et al.
Publicado: (2014)

The Role of Latency-Associated Transcripts in the Latent Infection of Pseudorabies Virus
por: Deng, Jiahuan, et al.
Publicado: (2022)

Pseudomonas aeruginosa Eliminates Natural Killer Cells via Phagocytosis-Induced Apoptosis
por: Chung, Jin Woong, et al.
Publicado: (2009)

High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes Comorbidity
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2022)

Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells
por: Krishna, B. A., et al.
Publicado: (2016)

The Human Cytomegalovirus Latency-Associated Gene Product Latency Unique Natural Antigen Regulates Latent Gene Expression
por: Poole, Emma, et al.
Publicado: (2023)

Epigenetic Control of Cytomegalovirus Latency and Reactivation
por: Liu, Xue-feng, et al.
Publicado: (2013)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells
por: Wang, Xinling, et al.
Publicado: (2022)

Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection
por: Krishna, Benjamin A., et al.
Publicado: (2017)

Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency
por: Telwatte, Sushama, et al.
Publicado: (2019)

CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells
por: Horvath, Riley M., et al.
Publicado: (2023)

Natural Killer Cells: Development, Maturation, and Clinical Utilization
por: Abel, Alex M., et al.
Publicado: (2018)

Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
por: Covino, Daniela A., et al.
Publicado: (2021)

The latency pattern of Epstein–Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas
por: Xu, Z-G, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_kv5gclvvmb92n13frro0qlbbtp